Breaking News

AcuraBio Acquired by Investors Dr. Glenn Haifer and Ampersand Capital Partners

Acquisition provides significant funding for new technologies and expanded services for the Australian biopharmaceutical CDMO.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AcuraBio (formerly Luina Bio), an Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, a global healthcare private equity firm.   With more than two decades of experience, AcuraBio is a globally focused organization bringing innovative therapeutics to market for customers in the biotech, pharmaceutical, and animal health industries. AcuraBio provides recombinant proteins and vaccines, and complex live biotherapeutic products ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters